BALDINI, LUCA
 Distribuzione geografica
Continente #
EU - Europa 13343
NA - Nord America 7067
AS - Asia 4391
SA - Sud America 221
AF - Africa 25
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 8
Totale 25078
Nazione #
US - Stati Uniti d'America 6731
GB - Regno Unito 6118
CN - Cina 2503
DE - Germania 1796
IT - Italia 1780
SE - Svezia 1337
UA - Ucraina 616
TR - Turchia 613
KR - Corea 546
RU - Federazione Russa 454
EU - Europa 377
FR - Francia 328
IN - India 327
CA - Canada 316
FI - Finlandia 274
NL - Olanda 263
VN - Vietnam 190
CO - Colombia 180
DK - Danimarca 80
PL - Polonia 68
JP - Giappone 61
GR - Grecia 54
CH - Svizzera 34
BE - Belgio 26
ES - Italia 26
HK - Hong Kong 26
RO - Romania 25
PH - Filippine 20
AU - Australia 19
UZ - Uzbekistan 17
BR - Brasile 16
MX - Messico 16
TW - Taiwan 15
IL - Israele 11
TH - Thailandia 10
PE - Perù 9
IR - Iran 8
NO - Norvegia 8
SG - Singapore 8
BG - Bulgaria 7
CL - Cile 7
PT - Portogallo 7
AT - Austria 6
EC - Ecuador 6
IE - Irlanda 6
PK - Pakistan 6
SC - Seychelles 6
EG - Egitto 5
MY - Malesia 5
ZA - Sudafrica 5
A2 - ???statistics.table.value.countryCode.A2??? 4
HR - Croazia 4
KW - Kuwait 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
CZ - Repubblica Ceca 3
ID - Indonesia 3
LI - Liechtenstein 3
LU - Lussemburgo 3
MD - Moldavia 3
MK - Macedonia 3
NG - Nigeria 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BD - Bangladesh 2
HU - Ungheria 2
LB - Libano 2
SN - Senegal 2
SV - El Salvador 2
TN - Tunisia 2
AP - ???statistics.table.value.countryCode.AP??? 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CU - Cuba 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
IQ - Iraq 1
KH - Cambogia 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MN - Mongolia 1
MT - Malta 1
NP - Nepal 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
VE - Venezuela 1
Totale 25452
Città #
Southend 5774
Seattle 873
Beijing 715
Princeton 696
Milan 664
Wilmington 545
Jacksonville 470
Redmond 354
Mountain View 340
Nanjing 331
Dearborn 308
Chandler 296
Fairfield 293
Ann Arbor 259
Somerville 259
Toronto 254
Sakarya 220
Andover 218
Serra 214
Des Moines 187
Hangzhou 179
Bogotá 177
Ashburn 176
Woodbridge 161
Houston 155
Jinan 140
Hanover 107
Shenyang 102
Nanchang 97
Kiez 89
Berlin 88
Guangzhou 85
Hebei 82
Grafing 81
Dong Ket 75
Tianjin 74
Cambridge 68
Redwood City 67
Changsha 66
Nürnberg 64
Saint Petersburg 56
Warsaw 55
Kunming 53
Shanghai 53
Seoul 51
Zhengzhou 50
Bitonto 48
Jiaxing 47
Roxbury 46
San Diego 45
Athens 44
Hamburg 39
Ottawa 39
Fuzhou 35
Odernheim 35
Norwalk 30
Hefei 29
Sunnyvale 27
Ningbo 25
Mumbai 24
Taizhou 24
Pisa 23
Phoenix 22
Falls Church 21
Fremont 21
Haikou 21
Verona 21
Costa Mesa 18
Istanbul 18
Lanzhou 18
Rome 17
Tokyo 17
Turin 17
San Jose 16
Taiyuan 16
Wuhan 16
Changchun 15
Auburn Hills 14
Brussels 14
Naples 14
New York 14
Los Angeles 13
Scranton 13
Chengdu 12
Modena 12
Cornate D'adda 11
Munich 11
Silver Spring 11
Bari 10
Brescia 10
Columbus 10
Dallas 10
Noginsk 10
Santa Clara 10
Bangalore 9
Chongqing 9
Medford 9
Bologna 8
Kwai Chung 8
Nichelino 8
Totale 16805
Nome #
Clinical-biological characterization of variant B chronic lymphocytic leukemia, characterized by a mantle cell lymphoma-like immunophenotype, t(11;14)(q13;q32) negative 359
R-chop vs R-mini-chop in elderly patients with diffuse large B-cell lymphoma (B-DLCL) prospectively selected by a multidimensional evalutation scale : preliminary results of a randomized study pc performed by intergruppo italiano linfomi (IIL) 280
ABVD versus modified Stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin lymphoma : final results of a multicenter, randomized trial by the Intergruppo Italiano Linfomi 270
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma 264
Upfront treatment of mantle cell lymphoma by sequential high dose immunochemotherapy supported by in vivo-purged stem cell double autologous transplantation : a single institution experience 242
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma : an "Intergruppo Italiano Linfomi" randomized trial 232
Identification of specific transcriptional patterns associated with hyperdiploidy in multiple myeloma 216
Prevalence of ras gene mutations in the context of a molecular classification of multiple myeloma 206
Frontline antiviral therapy in a series of HCV-related low grade non-Hodgkin lymphoma 178
Diagnostic role and prognostic significance of a simplified immunophenotypic classification of mature B cell chronic lymphoid leukemias 173
Molecular Classification of Multiple Myeloma : A Distinct Transcriptional Profile Characterizes Patients Expressing CCND1 and Negative for 14q32 Translocations 168
Gene Expression Profiling of Plasma Cell Dyscrasias Reveals Molecular Heterogeneity of Multiple Myeloma 164
Prevalence of ras gene mutations in the context of a molecular classification of multiple myeloma 162
Plasmablastic lymphoma of the stomach : a case report 159
The cytofluorimetric/FISH diagnostic approach define a B-cell variant-CLL with peculiar clinico-biologic features 157
Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature 157
Transcriptional features of 1Q in multiple myeloma 156
Clinical features of non Hodgkin's lymphomas associated with hepatitis C virus infection : study of the 'Registro lombardo dei linfomi HCV-positivi' (Lombardy Registry of HCV-positive lymphomas, Italy) 156
Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias : implication for MEK-ERK pathway activation 153
Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasias 152
UGT1A1 genotype does not affect tyrosine kinase inhibitors efficacy and safety in chronic myeloid leukemia 152
Granulomatosi di Wegener o linfoma extranodale? 145
Post-transplant lymphoproliferative disorders in liver and kidney recipients : a single institution experience 145
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias 145
Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses 142
Genome-wide analysis of DNA copy number in multiple myeloma using high-density SNP arrays reveals clustering patterns with distinct transcriptional profiles 139
11Q13 polisomy and absence of IGH translocations and chromosome 13Q14 deletion characterize a distinct subgroup of multiple myeloma patients expressing CCND 138
Molecular classification of Multiple Myeloma : a distinct trascriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocation 138
Clinico-biological characterization of a subset of variant B-CLL, defined according to a combined cytofluorimetric/fish diagnostic approach 137
IGHV gene analysis in chronic lymphocytic leukemia 135
A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias 134
Stereotyped patterns of B-CELL receptor in splenic marginal zone lymphoma 134
Analisi del numero di copie e sequenza del DNA in campioni sequenziali di melanoma alla diagnosi e recidiva=DNA copy number and whole-exome sequencing analyses in sequential myeloma samples at diagnosis and relapse 134
Functional and multimarker analysis of T-cell chronic lymphocytic leukaemia 133
Analysis of hiperdiploidy in Multiple Myeloma by fluorescence in situ hybridization. 130
Gene expression profiling of plasma cell dyscrasias reveals Multiple Myeloma molecula heterogeneity 130
Indolent B-cell lymphomas treated upfront with antiviral therapy : a series of 13 patients 129
R-chop vs R-mini ceop in elderly patients with diffuse large B cell lymphoma : an interim report from intergruppo italiano linfomi (IIL) 127
The clinico-biological features of a B-CLL variant, defined according to a combined cytofluorimetric/fish diagnostic approach 124
Molecular classification of multiple myeloma: a distinct profile characterizes patients expressing CCND1 and negative for 14q32 translocations 123
The prevalence and clinical implications of c-kit expression in plasma cell myeloma 123
Upregulation of translational machinery and distinct genetic subgroups characterise hyperdiploidy in multiple myeloma 122
Molecular classification of multiple myeloma : a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14Q32 translocations 122
Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma 122
Analysis of Stereotyped IGHV distribution in a series of 1133 chronic lymphocytic leukemia patients : the experience of a multicenter Italian Study Group 122
Epstein-Barr virus-associated lymphoma in Crohn's disease 121
Array-CGH in diffuse large B-cell lymphomas (DLBCL) treated with R-chop identifies recurrent 11Q24.3 aberrations 121
Genome-wide analysis of DNA copy number changes in multiple myeloma using high-density SNP arrays 120
Front-line treatment of low-grade non-follicular non-hodgkin lymphoma : final report of GISL LL02 trial 120
Array-CGH identifies regions, including the FOXP1 Locus, associated with different clinical outcome in diffuse large B-cell lymphomas (DLBCL) treated with R-CHOP 120
Gene expression profiling of multiple myeloma : implications for a molecular classification of the disease 120
Genome-wide analysis of DNA copy number changes in multiple myeloma using high-density SNP arrays 118
Transcriptional features of multiple myeloma patients with chromosome 1Q gain 118
A polycentric study ON CD5 negative chronic B cell leukemias 118
Integrative genomic analysis reveals distinct transcriptional and genetic features associated with chromosome 13 deletion in multiple myeloma 116
BIOLOGICAL CHARACTERIZATION OF REFRACTORY-ANEMIA WITH EXCESS OF BLASTS 116
Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia 115
Transcriptional features of multiple myeloma patients with chromosome 1q gain 114
A peculiar B-Cell subset, frequently IGVH hipermutated, is identified by a simplified immunophenotype-fish diagnostic algorithm 113
Molecular and transcriptional characterization of 17P loss in B-cell chronic lymphocytic leukemia 112
Integrative genomic analysis reveals distinct transcriptional and genetic features associated with 13 deletion in Multiple Myeloma 111
Brief chemoimmunotherapy rituximab ®-FND +/- R maintenance is effective and safe newly diagnosed follicular lymphoma elderly patients : an intergruppo italiano linfomi (IIL) randomized trial 111
The clinical and biological features of a series of immunophenotypic variant of B-CLL 111
Frontline treatment with the combination fludarabine-cyclophosphamide in low-grade non-follicular non-Hodgkin lymphoma : a long term updating of GISL LL02 trial 111
Gene and mirna expression profiles in plasma cell leukemias 110
Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell line 110
Low risk IgG Monoclonal Gammopathy of undetermined significance (MGUS) : proposal and validation of a prognostic scoring system 110
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) 110
Transcriptional features of multiple myeloma patients with chromosome 1Q gain 109
Unusual presentation of large B cell lymphoma : a case report and review of literature 109
Relationship between cytogenetic anomalies and biomarkers in Binet stage A patients with Chronic Lymphocytic Leukemia at diagnosis : preliminary results of a prospective, multicenter O-CLL1 GISL study 109
Retrospective analysis of salvage regimen for relapsed or refractory classical Hodgkin lymphoma 109
Splenic marginal zone lymphoma : a prognostic model for clinical use 108
Anthracycline-fludarabine containing regimens with or without rituximab in the treatment of advanced follicular lymphoma patients 108
ABDV vs Coppebvcad vs Beacopp for the initial treatment of patients with advanced hodgkin lymphoma (HL). Preliminary results of HD2000 GISL trial 108
Brief chemoimunotherapy with rituximab (R)- Find ± R maintenance as first treatment in adevanced follicular lymphoma (FL) in elderly : preliminary analysis of a prospective randomized trial 108
ABVD associated with imatinib for coexisting chronic myeloid leukaemia and relapsed Hodgkin lymphoma 107
Final report 50F GISL LL02 trials for thr treatment of low-grade non- follicular non- Hodgkin lymphoma, at diagnosis 106
Diagnostic Role of Flow Cytometry Analysis of Bioptical Samples in the Diagnosis of Lymphoid Tumors 106
Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas : final results of the LL02 trial of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 105
The length of treatment of aggressive non-Hodgkin's lymphomas established according to the international prognostic index score : long-term results of the GISL LA03 study 102
Reconstruction of transcriptional regulatory networks in multiple myeloma 102
Prognostic significance of abdominal CT scan in CLL patients in Binet Stage a : preliminary results of a prospective, multicenter observation –CLL1 - GISL study 102
Multimarker phenotypic characterization of adult and childhood acute lymphoblastic leukaemia: an Italian multicentre study 102
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection : a study on behalf of the Fondazione italiana linfomi 102
Enoxaparin, aspirin, or warfarin for thromboprophilaxis in newly diagnosed myeloma patients receiving thalidomide : a randomized controlled trial 101
CD 26 expression in mature B-cell neoplasia : its possible role as a new prognostic marker in B-CLL 100
Brief chemoimmunoterapy rituximab (R)-FND ± R maintenance as first line treatment in elderly patients with advanced follicular lymphoma (FL) : preliminary analysis of a prospective randomized IIL trial 100
Igm Mgus and indolent waldenstrom macrobulinemia recognise the same determinants of evolution into symptomatic lymphoid disordes. Proposal for a common prognostic scoring system 100
Prognostic significance of immunoglobulin phenotype in B cell chronic lymphocytic leukemia 99
Molecular analysis of 11q13 breakpoints in multiple myeloma 99
Gruppo Italiano studio linfomi (GISL) Criteria for defining disease-progression in indolent non follicular lymphoma 98
CD26 expression in mature B-cell neoplasia : its possible role as a new prognostic marker in B-CLL 97
Visual evoked potentials in patients with neuropathy and macroglobulinemia 96
Presence of circulating immune complexes in patients with chronic lymphocytic leukaemia. Correlations between clinical and immunological features 96
Fludarabine, cyclophosphamide and rituximab in patients with advanced untreated indolent B-cell non-follicular lymphomas : final result of phase two study of Fondazione Italiana Linfomi (FIL) 95
Clinical and molecular complete remission in a case of variant hairy cell leukemia treated with DHAP followed by high-dose chemotherapy plus rituximab 94
The role of 18F and 99MTC MIBI scintigraphy in predicting the clinical course of patients with multiple myeloma 94
Repetitive DNA hypomethylation in multiple myeloma 94
Primary chomoterapy with high-dose methotrexate (HD-MTX), cytarabine, thiotepa, and idarubicin (Matilde Regimen) followed by whole-brain irradiation for primari CNS lymphomas (PCNSL) : finel results of a multicenter, Italian phase trial 94
Totale 13234
Categoria #
all - tutte 34149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34149


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20182309 00234518 163407 85132 17315635883
2018/20193588 918243233116 70399 462172 251221302201
2019/20203546 509138214169 169406 367236 476525217120
2020/20214463 22433040478 377249 279222 5742771099350
2021/20223541 312132201126 277205 345172 598267189717
2022/20231276 6063802900 00 00 0000
Totale 27378